Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tolerability and safety of perampanel: two randomized dose-escalation studies.
Krauss GL, Bar M, Biton V, Klapper JA, Rektor I, Vaiciene-Magistris N, Squillacote D, Kumar D. Krauss GL, et al. Among authors: squillacote d. Acta Neurol Scand. 2012 Jan;125(1):8-15. doi: 10.1111/j.1600-0404.2011.01588.x. Epub 2011 Aug 29. Acta Neurol Scand. 2012. PMID: 21883097 Clinical Trial.
Perampanel Study 207: long-term open-label evaluation in patients with epilepsy.
Rektor I, Krauss GL, Bar M, Biton V, Klapper JA, Vaiciene-Magistris N, Kuba R, Squillacote D, Gee M, Kumar D. Rektor I, et al. Among authors: squillacote d. Acta Neurol Scand. 2012 Oct;126(4):263-9. doi: 10.1111/ane.12001. Epub 2012 Aug 23. Acta Neurol Scand. 2012. PMID: 22913800 Clinical Trial.
Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307.
Krauss GL, Perucca E, Ben-Menachem E, Kwan P, Shih JJ, Clément JF, Wang X, Bagul M, Gee M, Zhu J, Squillacote D. Krauss GL, et al. Among authors: squillacote d. Epilepsia. 2014 Jul;55(7):1058-68. doi: 10.1111/epi.12643. Epub 2014 May 27. Epilepsia. 2014. PMID: 24867391 Free PMC article. Clinical Trial.
Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307.
Krauss GL, Perucca E, Ben-Menachem E, Kwan P, Shih JJ, Squillacote D, Yang H, Gee M, Zhu J, Laurenza A. Krauss GL, et al. Among authors: squillacote d. Epilepsia. 2013 Jan;54(1):126-34. doi: 10.1111/j.1528-1167.2012.03648.x. Epub 2012 Aug 20. Epilepsia. 2013. PMID: 22905878 Free article. Clinical Trial.
Dosing feasibility and tolerability of intranasal diazepam in adults with epilepsy.
Sperling MR, Haas KF, Krauss G, Seif Eddeine H, Henney HR 3rd, Rabinowicz AL, Bream G, Squillacote D, Carrazana EJ. Sperling MR, et al. Among authors: squillacote d. Epilepsia. 2014 Oct;55(10):1544-50. doi: 10.1111/epi.12755. Epub 2014 Aug 25. Epilepsia. 2014. PMID: 25154625 Free article. Clinical Trial.
19 results